Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002

Abstract

A much higher risk for RA, AS, PsA, and MS was observed in IBD patients compared with controls. Prospective epidemiologic studies are needed to confirm these findings and explore the pathogenic mechanism of this relationship.